109 related articles for article (PubMed ID: 2550124)
1. Relation between DNA ploidy and the clinical behavior of phyllodes tumors.
Layfield LJ; Hart J; Neuwirth H; Bohman R; Trumbull WE; Giuliano AE
Cancer; 1989 Oct; 64(7):1486-9. PubMed ID: 2550124
[TBL] [Abstract][Full Text] [Related]
2. Stromal neoplasms of the breast: a comparative flow cytometric study.
El-Naggar AK; Mackay B; Sneige N; Batsakis JG
J Surg Oncol; 1990 Jul; 44(3):151-6. PubMed ID: 2164618
[TBL] [Abstract][Full Text] [Related]
3. Cystosarcoma phyllodes of the breast: histologic features, flow cytometric analysis, and clinical correlations.
Grimes MM
Mod Pathol; 1992 May; 5(3):232-9. PubMed ID: 1323101
[TBL] [Abstract][Full Text] [Related]
4. Phyllodes tumors of the breast: correlation of nucleolar organizer regions with histopathological malignancy grading, flow cytometric DNA analysis and clinical outcome.
Samaratunga H; Clarke B; Owen L; Bryson G; Swanson C
Pathol Int; 2001 Nov; 51(11):866-73. PubMed ID: 11844053
[TBL] [Abstract][Full Text] [Related]
5. Genome-wide analysis for loss of heterozygosity in primary and recurrent phyllodes tumor and fibroadenoma of breast using single nucleotide polymorphism arrays.
Wang ZC; Buraimoh A; Iglehart JD; Richardson AL
Breast Cancer Res Treat; 2006 Jun; 97(3):301-9. PubMed ID: 16791486
[TBL] [Abstract][Full Text] [Related]
6. DNA content and proliferative activity of cystosarcoma phyllodes of the breast. Potential prognostic significance.
el-Naggar AK; Ro JY; McLemore D; Garnsy L
Am J Clin Pathol; 1990 Apr; 93(4):480-5. PubMed ID: 2157332
[TBL] [Abstract][Full Text] [Related]
7. Distribution of MED12 mutations in fibroadenomas and phyllodes tumors of the breast--implications for tumor biology and pathological diagnosis.
Pfarr N; Kriegsmann M; Sinn P; Klauschen F; Endris V; Herpel E; Muckenhuber A; Jesinghaus M; Klosterhalfen B; Penzel R; Lennerz JK; Weichert W; Stenzinger A
Genes Chromosomes Cancer; 2015 Jul; 54(7):444-52. PubMed ID: 25931199
[TBL] [Abstract][Full Text] [Related]
8. Fibroepithelial lesions; The WHO spectrum.
Krings G; Bean GR; Chen YY
Semin Diagn Pathol; 2017 Sep; 34(5):438-452. PubMed ID: 28688536
[TBL] [Abstract][Full Text] [Related]
9. Clonal analysis of fibroadenoma and phyllodes tumor of the breast.
Noguchi S; Motomura K; Inaji H; Imaoka S; Koyama H
Cancer Res; 1993 Sep; 53(17):4071-4. PubMed ID: 8395336
[TBL] [Abstract][Full Text] [Related]
10. Prognostic evaluation of proliferative activity and DNA content in the phyllodes tumor of the breast: immunohistochemical and flow cytometric study of 118 cases.
Niezabitowski A; Lackowska B; Rys J; Kruczak A; Kowalska T; Mitus J; Reinfuss M; Markiewicz D
Breast Cancer Res Treat; 2001 Jan; 65(1):77-85. PubMed ID: 11245343
[TBL] [Abstract][Full Text] [Related]
11. Monoclonality in fibroadenomas with complex histology and phyllodal features.
Kasami M; Vnencak-Jones CL; Manning S; Dupont WD; Jensen RA; Page DL
Breast Cancer Res Treat; 1998 Jul; 50(2):185-91. PubMed ID: 9822223
[TBL] [Abstract][Full Text] [Related]
12. Aneuploidy in benign tumors and nonneoplastic lesions of musculoskeletal tissues.
Alho A; Skjeldal S; Pettersen EO; Melvik JE; Larsen TE
Cancer; 1994 Feb; 73(4):1200-5. PubMed ID: 8313323
[TBL] [Abstract][Full Text] [Related]
13. [Clinicopathologic features and prognostic factors of malignant phyllodes tumors].
Jia C; Mei F; Zheng J; You JF; Liu JY
Zhonghua Bing Li Xue Za Zhi; 2013 Nov; 42(11):729-34. PubMed ID: 24447548
[TBL] [Abstract][Full Text] [Related]
14. Pathologic, immunohistochemical, and molecular features of benign and malignant phyllodes tumors of the breast.
Kleer CG; Giordano TJ; Braun T; Oberman HA
Mod Pathol; 2001 Mar; 14(3):185-90. PubMed ID: 11266524
[TBL] [Abstract][Full Text] [Related]
15. Clinical course of cystosarcoma phyllodes related to histologic appearance.
Blichert-Toft M; Hansen JP; Hansen OH; Schiodt T
Surg Gynecol Obstet; 1975 Jun; 140(6):929-32. PubMed ID: 165582
[TBL] [Abstract][Full Text] [Related]
16. miR-21 induces myofibroblast differentiation and promotes the malignant progression of breast phyllodes tumors.
Gong C; Nie Y; Qu S; Liao JY; Cui X; Yao H; Zeng Y; Su F; Song E; Liu Q
Cancer Res; 2014 Aug; 74(16):4341-52. PubMed ID: 24980553
[TBL] [Abstract][Full Text] [Related]
17. [Phyllode tumors of the breast in 2 sisters].
Laumonier R; Pelfrene A; Julien J-P ; Brossard M; Chauzy C
Arch Anat Pathol (Paris); 1975 Mar; 23(1):61-6. PubMed ID: 168813
[No Abstract] [Full Text] [Related]
18. A five-gene reverse transcription-PCR assay for pre-operative classification of breast fibroepithelial lesions.
Tan WJ; Cima I; Choudhury Y; Wei X; Lim JC; Thike AA; Tan MH; Tan PH
Breast Cancer Res; 2016 Mar; 18(1):31. PubMed ID: 26961242
[TBL] [Abstract][Full Text] [Related]
19. Flow cytometric S fraction as a predictor of clinical outcome in cystosarcoma phyllodes.
Palko MJ; Wang SE; Shackney SE; Cottington EM; Levitt SB; Hartsock RJ
Arch Pathol Lab Med; 1990 Sep; 114(9):949-52. PubMed ID: 2167652
[TBL] [Abstract][Full Text] [Related]
20. p53 protein expression and gene mutation in phyllodes tumors of the breast.
Gatalica Z; Finkelstein S; Lucio E; Tawfik O; Palazzo J; Hightower B; Eyzaguirre E
Pathol Res Pract; 2001; 197(3):183-7. PubMed ID: 11314782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
